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Abstract:  Recent data suggest a possible involvement of Aquaporins (AQPs) in pain transmission. AQPs are small   
membrane channel proteins involved in osmoregulation and, to date, AQP1, AQP2, AQP3, AQP4, AQP5, AQP8   
and AQP9 have been found in the nervous system. Nevertheless only AQP1, AQP2 and AQP4 seem to be involved in  
nociception. 
In this review, direct and indirect evidences of the role of AQPs in pain processing will be reported.  
Keywords: Aquaporins, nervous system, sensory transmission, pain transmission.  
1. AQUAPORINS LOCALIZATION IN SENSORY 
NOCICEPTIVE STRUCTURES  
  AQP1 is expressed in peripheral nerve fibers that projects 
to the dorsal horn, which is involved in pain sensation [35]. 
In spinal cord AQP1 was observed in small afferent sensory 
nerve fibers [35]; specifically mRNA for AQP1 is concen-
trated in a subset of neuronal cell bodies in the dorsal root 
ganglia (DRG), but not in spinal cord neurons [40]. Moreo-
ver, AQP1 has been found in small diameter sensory neurons 
in dorsal root, trigeminal and nodose ganglia, but studies of a 
possible role for AQP1 in pain sensation have yielded con-
flicting results [35, 40]. Taken together, these data indicate 
that the spinal cord AQP1 derives exclusively from primary 
sensory neurons targeting neurons in the superficial dorsal 
horn. Osmotically induced swelling of the spinal cord was 
reduced in AQP1 knock-out mice [42] and markedly im-
paired pain sensation was demonstrated in response to ther-
mal (tail flick test) and chemical (capsaicin injection) stimuli 
[34], suggesting a role for AQP1 in neural signal transduc-
tion, and in rapid water recycling.  
  AQP2 expression is present in spinal cord, in subcortical 
white matter and hippocampus [28]. In addition, weak AQP2 
immunoreactivity is found in peripheral nerves [28] and   
in dorsal root and trigeminal ganglia neurons where the   
immunostaining is in the cytoplasm of each neuronal class 
[6, 7]. 
  AQP4 is the predominant subtype present in the brain 
[47] and spinal cord [33]. The most abundant site of AQP4 
expression in the brain and spinal cord is the perivascular 
glial processes [32, 33, 44]. In fact, AQP4 is a glial [43] 
membrane channel involved in cellular osmotic brain re-
gions, including the locus coeruleus and the ventral tegmen-
tal area (VTA) or the extended amygdala, nucleus accum-
bens, and prefrontal cortex [4] and knock-out of the Aqp4  
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gene modifies cocaine-related behaviours [24]. Additionally, 
AQP4 is localized in the Purkinje layer of the cerebellum, as 
well as in the supraoptic and paraventricular nuclei of the 
hypothalamus [32]. AQP4 is also expressed in ependymal 
cells, but is absent from neurons, oligodendrocytes, and mi-
croglia [32]. Water transport via AQP4 is essential for nor-
mal neuronal activity. Binder and co-workers [5] have shown 
that seizure susceptivity was increased in AQP4 deleted mice 
suggesting that glial water channels may modulate brain ex-
citability and the initiation and generalization of seizure ac-
tivity. 
  The presence of AQP3, AQP5, and AQP8, AQP9 was 
reported in central nervous system (CNS) [39], but their 
physiological role has not been fully analyzed. 
2.  EVIDENCES OF AQUAPORINS INVOLVEMENT 
IN PAIN TRANSMISSION 
2.1. AQP1 
  The role of AQP1 in pain processing is debated. 
  Three gene clusters containing 11 genes has been   
identified as a potential pool of candidate genes related to 
somatosensation in cranial structures such as the face, oral 
cavity and pharynx [27]; among them we find AQP1. The 
results suggested that the AQP1-positive cells are probably 
somatosensory neurons in two cranial sensory ganglia, the 
trigeminal and petrosal ganglia. The expression profiles   
and probable physiological functions of the 6 genes such   
as trkA, NaN and galanin suggest their direct involvement  
in specific somatosensory functions such as nociception. 
AQP1 has been identified in those ganglia and is expressed 
in small to medium size neurons with a diameter under 30 
um [27]. 
  The glial cells in the peripheral nervous system (PNS) 
express specifically AQP1 protein, while the astrocytes, the 
equivalent cells in the CNS, express AQP4 and AQP9 [12]. 
This finding suggests that members of the AQP family are 
differentially expressed in the PNS versus the CNS [12]. 
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concentrations of ions, metabolites, and neurotransmitters 
[41]. Increasing evidence indicates that glial cells function to 
coordinate the differentiation, metabolism, and excitability 
of neurons, to modulate synaptic transmission, and to inte-
grate signals from neurons and other glial cells [3, 11]. 
AQP1 expression in glial cells of the PNS suggests involve-
ment of channel-mediated water transport mechanisms in 
peripheral neuronal activity by regulating water homeostasis 
in the nerve plexuses and bundles, which warrants further 
investigations [12].  
  AQP1 has also an important role in synaptic vesicle swel-
ling that is critical for secretion. Recent study identifies 
AQP1, but also AQP6, associated with synaptic vesicles 
[17]. 
  In a communication of Oshio and co-workers [34] and 
after in a ‘commentary work’ of Verkmann [45], the infor-
mation that mice lacking AQP1 reduced nociception in re-
sponse to thermal stimuli and capsaisin was reported. After, 
the first complete work which attributed to AQP1 a role in 
pain transmission was published by Oshio and co-workers 
[35]. They observed that AQP1 is expressed in small afferent 
sensory nerve fibers in both the CNS and the PNS and that 
AQP1 deletion is associated with reduced behavioral re-
sponse to thermal and capsaicin chemical stimuli. These re-
sults suggested a functional role for AQP1 in nociceptive 
neurons [35]. The behavioral analysis demonstrated that 
AQP1 appears to contribute to the processing of two princi-
pal types of acute pain: thermal and chemical (capsaicin). It 
is of particular interest that the pain phenotype of AQP1 
knock-out mice is similar to TRPV1 (transient receptor po-
tential vanilloid 1) deficient mice which have normal re-
sponses to noxious mechanical stimuli and the formalin test 
[8]. 
  For acute thermal pain, both the AQP1 and TRPV1 null 
mice have reduced heat-evoked responses. AQP1 KO mice 
also have a significantly attenuated response to capsaicin, 
although not to the same degree as TRPV1 null mice where 
the response to capsaicin is completely lost. It is intriguing 
that dorsal root stimulation results in activity-dependent   
water flux specifically in the superficial dorsal horn of the 
spinal cord where AQP1 is expressed. Given the high surface 
area-to-volume ratio of small diameter C-fibers as compared 
to A-fibers, it has been speculated that AQP1 may be neces-
sary to dissipate osmotic gradients associated with rapid ion 
transport in these neurons. A similar mechanism has been 
proposed for AQP4 in facilitating K
+ ion flux in astroglia, 
Muller cells, and the supportive epithelial cells in the cochlea 
[25, 2]. Thus, it is possible that AQP1 may play a similar 
role in nociceptive neuronal ion homeostasis.  
  A number of previous studies have provided indirect evi-
dence of a contribution of osmosis in the pain pathway. Over 
30 years ago, Hitchcock and others reported that intrathecal 
injections of cold saline in patients with intractable pain led 
to immediate relief [14]. This effect was attributed to the 
osmolality and temperature of the solution. In other studies, 
Jewett and co-workers [18] and King and co-workers [20] 
used an in vitro preparation of dorsal roots from either mon-
keys or cats to examine the effects of saline of various osmo-
lalities on the firing of A and C-fibers. Interestingly, they 
found that distilled water or hypotonic saline resulted in dif-
ferential blockade of C-fibers, with little or no effect on A-
fibers. It was proposed that differences in water flux underlie 
the preferential conduction block of C-fibers. Although ana-
tomical differences between A and C-fibers were offered as a 
possible explanation, they suggested that the differential ex-
pression of AQP1 in C-fibers may account for the results and 
provide a molecular basis for osmosis in the pain pathway.  
  Other recent evidences support the hypothesis of a role of 
AQP1 in pain state [31]. Rat contusion spinal cord injury 
(SCI) induced persistent and significant four- to eightfold 
increases in AQP1 levels at the site of injury (T10) persisting 
up to 11 months post-contusion. Interestingly; AQP1 levels 
were not affected by long-lasting hypertonicity that signifi-
cantly increased astrocytic AQP4, suggesting that the pri-
mary role of AQP1 is not regulating isotonicity in spinal 
cords. They proposed possible novel roles for AQP1 in the 
injured spinal cords in neuronal and astrocytic swelling, as 
AQP1 was increased in all surviving neurons and reactive 
astrocytes after SCI and in the development of the neuro-
pathic pain after SCI. In fact, they have shown that decreased 
AQP1 in melatonin-treated SCI rats correlated with de-
creased AQP1 immunolabeling in the dorsal horns sensory 
afferents and with significantly decreased mechanical allo-
dynia, suggesting a possible link between AQP1 and chronic 
neuropathic pain after SCI [31]. 
  Moreover, AQP1 transports nitric oxide (NO) across cell 
membranes [13] that is NO transport is facilitated by a spe-
cific carrier such as AQP1. In fact, NO permeability of 
CHO-K1 cells (cell line from hamster ovary) increases with 
water permeability, which is a marker of AQP1 expression. 
This is the first direct evidence that an integral membrane 
transport protein facilitates diffusion of NO. Alterations in 
AQP-mediated NO transport may be an alternate explanation 
for many diseases and could be influence the neuromodula-
tion, in which NO is primarily implicated [26]. 
  A completely opposed point of view was primarily pro-
posed by Shields and co-workers [40]. Despite the heavy 
expression of AQP1 in nociceptors, and in marked disagree-
ment with recently published data [35], they found abso-
lutely no deficits in nociceptive processing in AQP1 mutant 
mice. It is important to observe that although AQP1 labeling 
in the dorsal horn changes after sciatic nerve transection, a 
manipulation that results in an altered pain state producing 
changes in nociceptor physiology, neither electrophysiologi-
cal nor a very complete behavioural analysis uncovered dif-
ferences in nociceptive processing between mice lacking 
AQP1 and wild-type mice. The reason for this discrepancy is 
not clear but is unlikely to be related to testing methods or to 
mouse background; these factors did not differ between the 
studies. Although each thermal pain assay measures a 
slightly different parameter, it is significant that in diverse 
tests of thermal pain sensibility (hindpaw radiant heat, hot 
plate, tail flick, thermal allodynia after nerve injury or CFA 
(complete Freund’s adjuvant) injection, and electrophysi-
ological responses to heat stimuli) it has been found that 
AQP1 knock-out mice process noxious heat stimuli normally.  
  Supporting these findings there are observations in   
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reported to be free from neurological dysfunction [37], and 
there is no indication that they have altered pain sensation. 
Moreover, in a recent work in a mouse model of formalin 
trigeminal acute inflammatory pain, there are no alterations 
in AQP1 expression in trigeminal ganglia as reported in Fig. 
(1) [6]. In addition, another recent work based on a neuro-
pathic rat model of chronic constriction injury (CCI) of sci-
atic nerve, reported no alteration of AQP1 expression both in 








Fig. (1). AQP1 immunostaining of trigeminal ganglia of control (a) 
and formalin (b) animals. The main microphotograph represent 
neurons while the inset-axons. Bar: 20um for (a) and (b); 5um for 
the insets (previously published in Borsani E et al., 2009 - El-
sevier). 
2.2. AQP2 
  Direct experimental evidences of AQP2 involvement   
in pain transmission have been published very recently. 
AQP2 expression undergoes interestingly changes in trige- 
minal ganglia during acute inflammation as reported in Fig. 
(2) [6]. In the control animals the AQP2 immunostaining 
showed general staining in the cytoplasm of each neuronal 
class, the staining was stronger in the medium- and large-
sized neurons than in the small one while neuronal mem-
branes were weakly positive; Schwann cells were negative 
and satellite cells were weakly positive. In formalin treated 
animals, AQP2 increased from a quantitative point of view 
and a redistribution in trigeminal ganglia cells was observed. 
AQP2 expression increased in the cytoplasm and neuronal 
membrane of small-sized neurons, while the AQP2 immu-
nostaining decreased in the cytoplasm of medium/large sized 
neurons with a strong increase in the neuronal membrane. 
Therefore, neuronal membranes had heavy staining in all 
neuronal classes, the Schwann cells and the satellite cells 
were highly positive compared to the control group. These 
observations lead to consider the redistribution of AQP pre-
sent in the cytoplasm in the membrane compartment for an 
adaptation in nociceptive condition.  
  Moreover, in the neuropathic rat model of chronic con-
striction injury (CCI) of sciatic nerve was assessed the altera-
tion of AQP2 expression in DRG [7]. CCI treatment induced 
a significant increase of AQP2 expression restricted to DRG 
and not in spinal cord. In DRG of CCI treated animals, Buf-
foli and co-workers [7] observed immunopositive neurons, 
scattered throughout the ganglia, showing a variable degree 
of staining; in particular, the most intensely stained cells 
were small diameter sized, therefore in the neurons that co-
label for markers of nociceptors as reported in Fig. (3). On 
the contrary, its expression was very weak in DRG of naïve 
and sham-operated rats and negative in spinal cord and sci-
atic nerve of all animals. Considering that the staining was 
localized mainly in the cytoplasm of small diameter sized 
neurons, these observations lead to consider the distribution 
of AQPs in the cytoplasm with respect to membrane com-
partment for an adaptation in chronic nociceptive condition 
in acute pain status. These could be related with the results 
obtained in trigeminal ganglia during acute inflammation, in 
which a redistribution of AQP2 in the neuronal membrane 
was observed [6]. Although there are evidences that AQP2 
mRNA is also present in human spinal cord [28], these re-
sults showed AQP2 staining only in DRG and not in the 
lumbar spinal cord. Moreover, CCI treatment did not induce 
AQP2 expression at the CCI injury site but in some small 
vessels of DRG. This could be due to the development of 


















Fig. (2). AQP2 immunostaining of trigeminal ganglia of control (a-
c) and formalin (d-f) animals. In formalin treated animals, a strong 
immunopositivity was found in cytoplasm of small-sized neurons 
(black thin arrow), neuronal membranes (white arrow), Schwann 
cells (black thick arrow) and satellite cells (head arrow). Bar: 20um 
(a, b, d, e); 10um (c, f) (previously published in Borsani E et al., 
2009 - Elsevier). 
  The exact mechanism by which AQP2 is enhanced is not 
clear. It is known that this protein translocates in response to 
arginine vasopressin (AVP) also in DRG [15, 19]. In particu-
lar, there are evidences that AVP induced hyperpolarization 
in the membrane of most DRG neurons which might be 
caused by K(+) outflow mediated by V1 receptor and that 
the membrane conductance of the DRG neurons increased 
following AVP application [15, 16].  
2.3. AQP4 
  AQP4 is a protein implicated in neurotransmission [45], 
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neurons [1], but only two experiments [22, 30] have been 
performed with the aim to link it to pain perception, and only 











Fig. (3). Immuohistochemical analysis of AQP2 expression in the 
DRG of CCI rats. (A) neuronal immunostaining was mainly intra-
cytoplasmatic, whereas the nucleus appeared unstained. (B) 
Schwann cells were weakly stained (thick arrows) and several small 
vessels were strongly immunopositive (thin arrows). Double im-
munofluorescence analysis of AQP2 (red) ⁄ NeuN (green) (C) 
AQP2 (red) ⁄ CD31 (green) (D) and AQP2 (red) ⁄ S100 (green) ex-
pression in DRG of CCI rats. Nuclei were stained in blue. Scale 
bars (A, B) 10 um, (C-E) 1 um (previously published in Buffoli B 
et al., 2009 - Wiley-Blackwell). 
  Nesic and co-workers [30] analysed AQP4 expression in 
central neuropathic pain (CNP) syndrome in a rat model of 
SCI, because it severely affects the quality of life of SCI 
patients. AQP4 is an astrocytic water channel protein that is 
typically up-regulated in activated astrocytes. DNA microar-
ray analysis showed significantly increased expression of a 
number of genes associated with inflammation and astrocytic 
activation in the spinal cords of rats that developed CNP. 
mRNA levels of glial fibrilary acidic protein (GFAP) and 
AQP4 significantly increased in CNP spinal cords of rats.   
A representative western blot shows low AQP4 expression  
in uninjured samples, and highly increased AQP4 protein 
levels in the CNP spinal cords, consistent with GFAP   
expression changes. Interestingly, GFAP and AQP4 are not 
only increased at the site of injury at 4 weeks after SCI, but 
also in the spinal segments away from the site of injury; in 
lumbar (L4/L5 combined) and in cervical (C7/C8 combined) 
segments in the spinal cords of rats with different level of 
CNP. 
  Opposing results were obtained by Lacroix and co-
workers [22]. They aimed to identify significative alteration 
of AQP4 in a rat model of lumbar radiculopathy (L5 nerve 
root ligation) and neuropathy (L5 spinal nerve transection). 
The authors measured mechanical allodynia followed by 
analysis of global gene expression in the lumbar spinal cord 
at two time points (7 days and 14 days). Finally, they did not 
observe significant difference in AQP4 expression between 
any of the treatment groups. 
  These contrasting results lead our attention to the com-
plexity of AQP function probably linked to the experimental 
model. 
  Other recent experiments link AQP4 to sensory transduc-
tion and could induce to correlate the results to a possible 
role of this water channel to pain transmission, even if other 
direct correlation was never directly done.  
  Evidences showed that AQP4 plays an important role in 
functions of astrocyte, such as astroglial migration, K
+ buff-
ering, and neuronal activities [5, 36, 38]. In astrocytes, 
AQP4 coexists extensively with inward rectifying K
+ chan-
nel 4.1 (Kir 4.1), glial glutamate transporter 1 (GLT1) and 
glutamate/aspartate transporter (GLAST), the major trans-
porters responsible for clearance of extracellular glutamate 
[29, 32, 46, 49]. Additionally, ultrastructural examinations 
showed that astrocytes AQP4-positive processes surround 
certain synapses (excitatory and inhibitor synapses) [32, 46]. 
These indicate that AQP4 might modulate excitatory synap-
tic transmission. Glutamate is the principle excitatory neuro-
transmitter in the CNS, which participates in many physio-
logical functions and pathological processes including noci-
ception which suggests that AQP4 could modulate K
+ and 
glutamate homeostasis.  
  In brain, seizure susceptibility in response to the convul-
sant (GABA antagonist) pentylenetetrazol was remarkably 
increased in AQP4 null mice [5]. Some investigations have 
demonstrated that the lack of AQP4 expressions in mice is 
paralleled by sex- and region-specific alterations in neuro-
transmission [10]. Therefore, AQP4 may serve as a modula-
tor of astroglial function including regulating neurotransmit-
ter release in mammalian brain. AQP4 deficiency influences 
K
+-stimulated releases of striatal neurotransmitters [9].  
  AQP4 may play a role in regulating extracellular cocaine-
induced dopamine and glutamate release in the brain reward 
center, and in turn AQP4 deletion may attenuate cocaine 
reinforcement and dependence [24].  
  Wu and co-workers [48] presumed that there might be a 
relationship between AQP4 and opioid analgesia, tolerance 
and dependence processes through glial glutamate transport-
ers and glutamatergic neurotransmission. A reduction in ba-
sal GLT1 expression in cerebrum was observed in AQP4 
knock-out mice. Compared with wild-type mice, the basal 
GLT1 expression in cerebrum was decreased by 23.1% and 
26.5% in male and female AQP4 knock-out mice, respec-
tively. Moreover, AQP4 deficiency potentiated morphine 
analgesia, attenuated morphine tolerance and physical de-
pendence; the suppression of down-regulation of GLT1 ex-
pression might mediate the attenuation of AQP4 deficiency 
to morphine tolerance and dependence [48]. 
  Recently, some evidences suggest that neural activity-
dependent astrocyte swelling is likely to be mediated by wa-
ter influx through AQP4 water channels [21]. 
CONCLUSIONS 
  The role of AQPs in pain processing is today in open 
debate. It is true that a lot of direct and indirect evidences 
strongly lead to hypothize an active role in pain modulation, 
but important data do not agree with this. So, although there 
is not in literature a unidirectional way on this point, the   
inter-relationship between nervous system/neurotransmission 126    Current Neuropharmacology, 2010, Vol. 8, No. 2  Elisa Borsani 
and AQPs is otherwise an undisputed embraced new   
concept. 
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